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thoracic and lumbar myofascial syndrome (MFS): systematic review of the
literature.
Results.– For the neck, the cervico-thoracic SMF concern the upper trapezius,
supraspinatus, rhomboids, angular, and cervical paraspinal muscles [1]. After
BT injection, prospective studies show an improvement in pain and quality of
life for 3 months. Randomized controlled trials (RCT) found at 1 and 3 months
analgesics and functional results with BT equivalent to other products (saline,
corticosteroids) and dry needle therapy. Two RCTs show a greater analgesic and
functional effect 1 and 2 months after BT injections compared to saline solution.
For upper limb pain, one RCT (MFS of the scalene muscle), shows after BT
injection an analgesic gain at two months superior to corticosteroid injections.
For low back pain, the MFS concern iliopsoas, erector spinae and rectus of the
abdomen. Foster et al. [2] show that after injection of TB in the erector spinae
muscles, pain relief and functional gain to 1 and 2 months are greater than the
saline injection. Similar results were found compared to traditional treatment by
acupuncture.
Conclusions.– The use of BT in the treatment of neck pain and low back pain is
an interesting alternative therapeutic in axial MFS. Its superiority compared to
other treatments remains to be demonstrated.
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Purpose.– Rehabilitation of orthopaedic articular stiffness represents a major
therapeutic challenge. In rebellious cases, injection of botulinic toxin in bi-
articular muscles could represent an interesting adjunction to the usual
therapies.
Observations.–
– A 29-years-old female patient hospitalised after her fourth knee arthrolysis
following an anterior cruciate ligament reconstruction. At admission, the ROM
was F/E 908-0-58. Rapidly a 258 stiff knee flexion appears with important
difficulties while walking. The electro-neuromyography shows a hyperactivity
of hamstrings semi-membranous and short head of the femoral biceps muscles.
Injections of 100U of botulinic toxin in femoral biceps, 50U in the others
hamstrings and gastrocnemius muscles were done. After 3 weeks the stiff knee
flexion progressively reduces (F/E 1258-5-08), pain reduces by 30% and
walking improves (see videos). At 3 and 6 months, injections were repeated for
a persistent muscular hyperactivity. At 1 year, the pattern of walking is back to
normal. The patient has fully returned to work and started adapted sport
activities.
– A 34 years old patient that had surgery for a radial head dislocation and
fracture. Osteosynthesis material was taken off 13months followed by a
secondary stiffening resisting ambulatory treatment. At entry, the ROM was
F/E 1308-608-0 with a stiff stop in extension. Prono/supp 808-0-608. On theEMG: biceps muscular hyperactivation. Injection of 25U of botulinic toxin in
biceps short head followed by intensive physiotherapy and occupational therapy
for 5 weeks. Decrease in biceps hypertonia 7 days after the injection. ROM at
discharge F/E 1358-128-0, P/S 808-0-608. Progressive return to work as a
heating engineer achieved. At 3 months: F/E: 1308-258-0, P/S: 808-0-608.
Discussion.– Most often used in treatment of spasticity, botulin toxin could in
some cases allow to break a vicious circle. The neuromouscular blockade allows
a decrease in muscular tonus and facilitates rehabilitation. The toxin transported
through the axons to the central nervous system and the adjacent neurones also
show an analgesic effect through the modulation of some neurotransmitters’
secretion such as the substance P, CGRP and glutamate.
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Objective.– The piriformis muscle syndrome (PMS) arises a problem as
diagnostic because there are not clinical and paraclinical pathognomonic signs,
as therapeutic. The chronic PMS can be treated by muscular injection of
botulinum toxin (BTA). The objective is to assess the efficiency and the interest
of BTA.
Methods and patients.– Retrospective study of 46 patients treated by piriformis
injection of BTA guided by CT. Clinical, electrological and imaging diagnosis
rules out the spine and pelvic causes of buttock pain and/or sciatalgia. Pain
assessment by the patient: decrease < or  50% of the pre-therapeutic pain.
Results.– Sixteen patients are examined at 4 months: 62,5% of good results
(pain decrease  50%). Second BTA injection in 12 patients: 63% of good
results but during only 1 month. Third BTA injection in three patients: 100% of
good results during only 1 month. Phone assessment of 14 patients with initial
good results: Five patients think to have a partial benefit continuing at mean 30
months. Correlation don’t exist between results and age, the time elapsed since
the beginning of the PMS (mean 33  44 months), the low back pain, the
location of the pain, the electrological modifications of the H reflex.
Discussion.– Four published studies find a statistically significant efficiency of
the BTA between 2 and 4 months. In our study these good results don’t last more
long time. The BTA injection repetition don’t give a cumulative effect and the
efficiency even decreases. So, the therapeutic interest is limited. On the other
hand the BTA transitory efficiency at short-term could be used to confirm the
diagnosis of PMS because BTA has its principal action in muscle without
diffusion, contrary the corticoids.
Conclusion.– The BTA injection into the piriformis muscle for the chronic or
resistant PMS is becoming for us a certain diagnosis test associated to clinical
and paraclinical signs for the aim to better select the patients to a surgical
treatment. Nevertheless, the validity of this strategy must be confirmed by a
prospective study.
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